Skip to content
“Here you can find summaries of landmark clinical trials and studies in classical hematology classified into different topics.”
Thrombosis
- PACIFIC AF Trial (2022) – Oral Factor XI Inhibitor Asundexian Versus Apixaban in Atrial Fibrillation (2022)
- AMPLIFY-EXT (2013) – Apixaban for the Extended Treatment of Venous Thromboembolism (full-dose vs half-dose apixaban)
